A recent study found that in MUC1.Tg mouse models, peptide vaccination consisting of two different 9-polymers derived from MUC-1 combined with CpG oligonucleotides and granulocyte–macrophage colony–stimulating factor (GM-CSF) as adjuvants reduced tumor load. This evidence concerns the gene MUC1 and neoplasm.